- Yale Digestive DiseasesTemple Medical Center40 Temple Street, Ste 1ANew Haven, CT 06510
- 8 Devine StreetNorth Haven, CT 06473
Jill Gaidos, MD
Biography
Jill Gaidos, MD, specializes in treating patients with inflammatory bowel disease (IBD), an umbrella term describing two conditions that cause chronic inflammation within the digestive system: ulcerative colitis and Crohn’s disease.
Dr. Gaidos says she was drawn to IBD because of its variety. “I like how sometimes I get to perform a procedure and see a patient only once; but, I also get to care for others over the span of many years,” she says. “You have to think about the entire patient—it’s a mix of acute and chronic cases.”
Dr. Gaidos enjoys helping patients better understand their IBD and the medications that can be used to help treat their colitis or Crohn’s disease. “My goal is to get the patient to return to enjoying life again,” she says. “It’s rewarding when a patient tells me they had no idea how bad they had been feeling until they started to feel better.”
As the director of clinical research for the Yale Inflammatory Bowel Disease Program, Dr. Gaidos helps patients understand the treatment options available, as not all IBD medications work for all IBD patients. “We are learning more about what causes ulcerative colitis and Crohn’s disease,” she says. “Hopefully, one day we will be able to better predict which patients we can put on a particular drug that will work for them.”
Titles
- Associate Professor of Medicine (Digestive Diseases)
- Director of Clinical Research, Yale Inflammatory Bowel Disease Program
- Vice Chief of Clinical Research, Digestive Diseases
Education & Training
- FellowUniversity of Florida (2011)
- ResidentVirginia Commonwealth University (2008)
- InternshipVirginia Commonwealth University (2006)
- MDVirginia Commonwealth University, Medicine (2005)
Additional Information
- Crohn’s and Colitis Foundation Women in IBD Leadership Program: (2022)
- American College of Gastroenterology Advanced Leadership Development Program: (2022)
- Cassell Connolly Top Doctor for 2022: (2022)
- 2021 Crohn’s and Colitis Congress, Crohn’s and Colitis Champion: (2020)
- 2020 Crohn’s and Colitis Congress, Crohn’s and Colitis Champion: (2019)
- Crohn’s and Colitis Foundation, Healthcare Provider Volunteer Award: (2018)
- American College of Gastroenterology, Fellow: (2014)
- American College of Gastroenterology, Chair: (2014)
- American College of Gastroenterology, Inflammatory Bowel Disease Abstract Award: (2012)
- Investing in the Future: Clinical Research in Inflammatory Bowel Disease Program: (2011)
- McMillan C, Li D, Mohamed G, Alsadoun D, Almohsen L, Gaidos J, Proctor D, Al-Bawardy B. Longer Colonoscopy Withdrawal Time Is Associated With the Detection of Visible Dysplasia in Patients With Inflammatory Bowel Disease. Crohn's & Colitis 360 2024, 6: otae020. PMID: 38585555, PMCID: PMC10998460, DOI: 10.1093/crocol/otae020.
- Sahyoun L, Fetene J, McMillan C, Protiva P, Al Bawardy B, Gaidos J, Proctor D. Impact of COVID-19 Treatment on Real-World Outcomes in Inflammatory Bowel Disease. Digestive Diseases And Sciences 2024, 69: 1654-1660. PMID: 38466459, DOI: 10.1007/s10620-024-08355-3.
- Sahyoun L, McMillan C, Fetene J, Protiva P, Al-Bawardy B, Gaidos J, Proctor D. S1000 Exploring the Influence of COVID-19 Treatment on Real-World Outcomes in IBD Patients: A Comprehensive Analysis. The American Journal Of Gastroenterology 2023, 118: s757-s757. DOI: 10.14309/01.ajg.0000953640.32433.d2.
- Almomen H, Alomar I, McMillan C, Gaidos J, Proctor D, AlMutairdi A, Al-Bawardy B. S1006 Comparison of Upadacitinib Induction in Tofacitinib Exposed and Naïve Patients With Inflammatory Bowel Disease: A Real World Multi-Center Study. The American Journal Of Gastroenterology 2023, 118: s761-s762. DOI: 10.14309/01.ajg.0000953664.83573.de.
- Levine L, Liang Y, McMillan C, Jain D, Mohamed G, Almohsen L, Alsadoun D, Gaidos J, Proctor D, Al-Bawardy B. S940 Histologic Healing in Crohn's Disease Is Not Associated With Long Term Outcomes. The American Journal Of Gastroenterology 2023, 118: s704-s705. DOI: 10.14309/01.ajg.0000953400.77190.37.
- Vasudevan J, Damianos J, DiVincenzo C, Gaidos J, Burgermaster M, Feagins L. S947 Why IBD Patients Aren’t Eating ‘an Apple a Day:’ Understanding Dietary Fiber Avoidance in Inflammatory Bowel Disease. The American Journal Of Gastroenterology 2023, 118: s710-s711. DOI: 10.14309/01.ajg.0000953428.77556.69.
- Chavez V, Vasudevan J, Ochi M, Sahyoun L, Kogan L, Anand T, Gaidos J, Feagins L. S1007 No Impact of Primary Language on Treatment and Outcomes for Patients With Inflammatory Bowel Disease in 2 Academic Medical Centers. The American Journal Of Gastroenterology 2023, 118: s762-s763. DOI: 10.14309/01.ajg.0000953668.62572.df.
- Xiao K, Gottesman S, Nguyen H, Hernandez E, Anand T, Saweris E, Jaganathan P, Jafri F, Davis J, Tong K, Gaidos J, Feagins L. S1009 Higher Rates of Delay in Starting Advanced Inflammatory Bowel Disease Therapy for Biologics Given Via Infusion Centers. The American Journal Of Gastroenterology 2023, 118: s764-s765. DOI: 10.14309/01.ajg.0000953676.10735.44.
- Hedrick T, Sherman A, Cohen-Mekelburg S, Gaidos J. AGA Clinical Practice Update on Management of Ostomies: Commentary. Clinical Gastroenterology And Hepatology 2023, 21: 2473-2477. PMID: 37498275, DOI: 10.1016/j.cgh.2023.04.035.
- Gaidos J, Bawardy B, Farraye F, Regueiro M. Use of Standardized Inflammatory Bowel Disease Endoscopy Scores in Clinical Practice. Crohn's & Colitis 360 2023, 5: otad037. PMID: 37559746, PMCID: PMC10407976, DOI: 10.1093/crocol/otad037.
- Sharma S, Li D, Levine L, Chaar A, McMillan C, Gaidos J, Proctor D, Al-Bawardy B. Early Flexible Sigmoidoscopy Improves Clinical Outcomes in Acute Severe Ulcerative Colitis. Crohn's & Colitis 360 2023, 5: otad032. PMID: 37323477, PMCID: PMC10263117, DOI: 10.1093/crocol/otad032.
- Vasudevan J, Larson D, Damianos J, Shori C, DiVincenzo C, Ishola Y, Gaidos J, Burgermaster M, Feagins L. Mo1714 DIETARY FIBER INTAKE ASSOCIATED WITH REDUCED IBD DISEASE ACTIVITY. Gastroenterology 2023, 164: s-876-s-877. DOI: 10.1016/s0016-5085(23)03024-x.
- Almomen H, Sayed A, Chipkin B, Nawaz A, Gaidos J, Proctor D, Bawardy B. Tu1796 OUTCOMES OF ACCELERATED VS. STANDARD INFLIXIMAB INDUCTION DOSE IN CROHN'S DISEASE. Gastroenterology 2023, 164: s-1132. DOI: 10.1016/s0016-5085(23)03611-9.
- McMillan C, Li D, Gaidos J, Proctor D, Bawardy B. 113 LONGER COLONOSCOPY WITHDRAWAL TIME IS ASSOCIATED WITH THE DETECTION OF POLYPOID DYSPLASIA IN INFLAMMATORY BOWEL DISEASE. Gastroenterology 2023, 164: s-16. DOI: 10.1016/s0016-5085(23)00993-9.
- Al-Bawardy B, Malter L, Ehrlich A, Rieder F, Gaidos J, Proctor D, Windish D. Assessment of Inflammatory Bowel Disease Training Among Gastroenterology Fellows. Inflammatory Bowel Diseases 2023, 29: 1990-1992. PMID: 36810663, DOI: 10.1093/ibd/izad030.
- Sayed A, Assis D, Silveira M, Deng Y, Ciarleglio M, Gaidos J, Proctor D, Al-Bawardy B. Outcomes of immunomodulator and advanced therapies for primary sclerosing cholangitis-associated inflammatory bowel disease. European Journal Of Gastroenterology & Hepatology 2023, 35: 270-274. PMID: 36708297, DOI: 10.1097/meg.0000000000002510.
- Sahyoun L, Gaidos J. A Practical Approach to IBD Care in the Pregnant Patient. Current Gastroenterology Reports 2022, 24: 201-209. PMID: 36422770, DOI: 10.1007/s11894-022-00856-3.
- Anderson J, Bilal M, Burke C, Gaidos J, Lopez R, Oxentenko A, Surawicz C. Burnout Among US Gastroenterologists and Fellows in Training. Journal Of Clinical Gastroenterology 2022, 57: 1063-1069. PMID: 36477385, DOI: 10.1097/mcg.0000000000001781.
- Sharma S, Li D, Levine L, Chaar A, McMillan C, Gaidos J, Proctor D, Al-Bawardy B. S856 Predictors of Colectomy in Acute Severe Ulcerative Colitis. The American Journal Of Gastroenterology 2022, 117: e618-e619. DOI: 10.14309/01.ajg.0000860064.59694.03.
- Nawaz A, Chaar A, Li D, Gaidos J, Proctor D, Al-Bawardy B. S863 Impact of Race on ANTI-TNF Immunogenicity in Patients with Inflammatory Bowel Disease. The American Journal Of Gastroenterology 2022, 117: e623-e624. DOI: 10.14309/01.ajg.0000860092.19979.d5.
- McMillan C, Levine L, Gaidos J, Proctor D, Al-Bawardy B, Jain D, Liang Y. S862 Rates and Outcomes of Histologic Healing in Crohn's Disease. The American Journal Of Gastroenterology 2022, 117: e622-e623. DOI: 10.14309/01.ajg.0000860088.69814.32.
- Al-Bawardy B, Malter L, Ehrlich A, Rieder F, Gaidos J, Proctor D, Windish D. S875 Assessment of Inflammatory Bowel Disease Training Among Gastroenterology Fellows. The American Journal Of Gastroenterology 2022, 117: e632-e632. DOI: 10.14309/01.ajg.0000860140.96667.49.
- Shori C, Damianos J, DiVincenzo C, Ishola Y, Larson D, Burgermaster M, Gaidos J, Feagins L. S1011 Inflammatory Bowel Disease Patients Commonly but Inconsistently Change Diet for Flares. The American Journal Of Gastroenterology 2022, 117: e732-e733. DOI: 10.14309/01.ajg.0000860684.14143.a0.
- Feagins L, Moore P, Crabtree M, Lemay C, Loughlin A, Gaidos J. S883 Impact of Fatigue on Work Productivity and Activity Impairment and Health Care Utilization in Patients With Inflammatory Bowel Disease. The American Journal Of Gastroenterology 2022, 117: e639-e640. DOI: 10.14309/01.ajg.0000860172.94404.2d.
- Gaidos J, Al-Bawardy B, Farraye F, Regueiro M. S1013 Use of IBD Endoscopic Scoring Systems in Practice. The American Journal Of Gastroenterology 2022, 117: e733-e734. DOI: 10.14309/01.ajg.0000860692.83055.c3.
- Di Vincenzo C, Damianos J, Shori C, Ishola Y, Chebaa B, Koshar P, Burgermaster M, Gaidos J, Feagins L. Tu1434: RETHINKING LOW FIBER DIETS FOR ACTIVE INFLAMMATORY BOWEL DISEASE. Gastroenterology 2022, 162: s-958. DOI: 10.1016/s0016-5085(22)62272-8.
- Sharma S, Levine L, McMillan C, Li D, Gaidos J, Proctor D, Bawardy B. Mo1547: IMPACT OF EARLY VS DELAYED FLEXIBLE SIGMOIDOSCOPY ON OUTCOMES IN INPATIENT SEVERE ULCERATIVE COLITIS. Gastroenterology 2022, 162: s-813. DOI: 10.1016/s0016-5085(22)61919-x.
- Levine L, Sharma S, McMillan C, Li D, Gaidos J, Proctor D, Bawardy B. Tu1429: FREQUENCY AND CHARACTERISTICS OF NUTRITION ASSESSMENT IN HOSPITALIZED ULCERATIVE COLITIS PATIENTS. Gastroenterology 2022, 162: s-957. DOI: 10.1016/s0016-5085(22)62267-4.
- Sayed A, Silveira M, Assis D, Deng Y, Gaidos J, Proctor D, Al-Bawardy B. PREDICTORS AND OUTCOMES OF BIOLOGIC/IMMUNOSUPPRESSIVE THERAPY FOR PSC-ASSOCIATED IBD. Gastroenterology 2022, 162: s76. DOI: 10.1053/j.gastro.2021.12.161.
- Petrov J, Al-Bawardy B, Gaidos J, Proctor D. OUTCOMES OF TOTAL PROCTOCOLECTOMY (TPC) WITH ILEAL POUCH ANAL ANASTOMOSIS (IPAA). Gastroenterology 2022, 162: s75-s76. DOI: 10.1053/j.gastro.2021.12.160.
- Nawaz A, Glick L, Li D, Gaidos J, Proctor D, Al-Bawardy B. IMPACT OF THIOPURINE DOSE IN COMBINATION THERAPY IN INFLAMMATORY BOWEL DISEASE. Gastroenterology 2022, 162: s107-s108. DOI: 10.1053/j.gastro.2021.12.221.
- Sayed A, Silveira M, Assis D, Deng Y, Gaidos J, Proctor D, Al-Bawardy B. PREDICTORS AND OUTCOMES OF BIOLOGIC/IMMUNOSUPPRESSIVE THERAPY FOR PSC-ASSOCIATED IBD. Inflammatory Bowel Diseases 2022, 28: s76-s76. DOI: 10.1093/ibd/izac015.124.
- Petrov J, Al-Bawardy B, Gaidos J, Proctor D. OUTCOMES OF TOTAL PROCTOCOLECTOMY (TPC) WITH ILEAL POUCH ANAL ANASTOMOSIS (IPAA). Inflammatory Bowel Diseases 2022, 28: s75-s76. DOI: 10.1093/ibd/izac015.123.
- Nawaz A, Glick L, Li D, Gaidos J, Proctor D, Al-Bawardy B. IMPACT OF THIOPURINE DOSE IN COMBINATION THERAPY IN INFLAMMATORY BOWEL DISEASE. Inflammatory Bowel Diseases 2022, 28: s107-s108. DOI: 10.1093/ibd/izac015.174.
- Nawaz A, Glick L, Chaar A, Li D, Gaidos J, Proctor D, Al-Bawardy B. Impact of thiopurine dose in anti-tumor necrosis factor combination therapy on outcomes in inflammatory bowel disease. Annals Of Gastroenterology 2022, 36: 39-44. PMID: 36593807, PMCID: PMC9756033, DOI: 10.20524/aog.2022.0766.
- Levine L, Gaidos J, Proctor D, Viana A, Bawardy B. Su465 EFFECT OF OBESITY ON VEDOLIZUMAB RESPONSE IN INFLAMMATORY BOWEL DISEASE. Gastroenterology 2021, 160: s-703-s-704. DOI: 10.1016/s0016-5085(21)02387-8.
- Li M, Khan S, Gaidos J, Proctor D, Bawardy B. Sa566 OUTCOMES OF INFLAMMATORY BOWEL DISEASE WITH CONCOMITANT ADVANCED LIVER FIBROSIS AND CIRRHOSIS. Gastroenterology 2021, 160: s-554. DOI: 10.1016/s0016-5085(21)02022-9.
- Levine L, Gaidos J, Proctor D, Bawardy B. Su464 PREDICTORS AND OUTCOMES OF VEDOLIZUMAB DOSE ESCALATION IN INFLAMMATORY BOWEL DISEASE. Gastroenterology 2021, 160: s-703. DOI: 10.1016/s0016-5085(21)02386-6.
- Li M, Khan S, Proctor D, Gaidos J, Al-Bawardy B. THE SAFETY, TOLERABILITY, AND EFFECTIVENESS OF BIOLOGICS/SMALL MOLECULE THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND CIRRHOSIS. Gastroenterology 2021, 160: s62. DOI: 10.1053/j.gastro.2021.01.159.
- Li M, Khan S, Proctor D, Gaidos J, Al-Bawardy B. THE SAFETY, TOLERABILITY, AND EFFECTIVENESS OF BIOLOGICS/SMALL MOLECULE THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND CIRRHOSIS. Inflammatory Bowel Diseases 2021, 27: s45-s46. DOI: 10.1093/ibd/izaa347.110.
- Gaidos JKJ, Kane SV. Medication Adherence During Pregnancy in IBD: Compliance Avoids Complications. Digestive Diseases And Sciences 2020, 66: 336-337. PMID: 32323073, DOI: 10.1007/s10620-020-06271-w.
- Malter L, Jain A, Cohen BL, Gaidos JKJ, Axisa L, Butterfield L, Rescola BJ, Sarode S, Ehrlich O, Cheifetz AS. Identifying IBD Providers’ Knowledge Gaps Using a Prospective Web-based Survey. Inflammatory Bowel Diseases 2020, 26: 1445-1450. PMID: 32100018, DOI: 10.1093/ibd/izaa032.
- Gaidos J, Naik K, Dave J, Yao M, Hou J, Cipher D, Smith A, Feagins L. High Prevalence of Male Sexual Dysfunction in a Prospective Multicenter VA Inflammatory Bowel Disease Population. Crohn's & Colitis 360 2020, 2: otaa004. PMID: 36777954, PMCID: PMC9801960, DOI: 10.1093/crocol/otaa004.
- Thakur ER, Sansgiry S, Kramer JR, Waljee AK, Gaidos JK, Feagins LA, Govani SM, Dindo L, El-Serag HB, Hou JK. The Incidence and Prevalence of Anxiety, Depression, and Post-traumatic Stress Disorder in a National Cohort of US Veterans With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2019, 26: 1423-1428. PMID: 31728520, PMCID: PMC7441098, DOI: 10.1093/ibd/izz280.
- Pawa S, Banerjee P, Kothari S, D'Souza S, Martindale S, Gaidos J, Oxentenko A, Burke C. 515 Are All Endoscopic-Related Musculoskeletal Injuries Created Equal?: Results of a National Gender-Based Survey. The American Journal Of Gastroenterology 2019, 114: s299-s299. DOI: 10.14309/01.ajg.0000591592.66925.e8.
- Feagins LA, Kim J, Chandrakumaran A, Gandle C, Naik KH, Cipher DJ, Hou JK, Yao MD, Gaidos JKJ. Rates of Adverse IBD-Related Outcomes for Patients With IBD and Concomitant Prostate Cancer Treated With Radiation Therapy. Inflammatory Bowel Diseases 2019, 26: 728-733. PMID: 31412114, DOI: 10.1093/ibd/izz175.
- Love B, Finney C, Gaidos J. Sa1782 – Effect of Vaccination and Immunosuppressive Medications on Invasive Pneumococcal Disease Occurrence in Veterans with Inflammatory Bowel Disease. Gastroenterology 2019, 156: s-400. DOI: 10.1016/s0016-5085(19)37849-7.
- Feagins L, Kim J, Chandrakumaran A, Gandle C, Naik K, Hou J, Yao M, Gaidos J. Mo1862 – No Increaed Rates of Adverse Ibd-Related Outcomes for Patients with IBD and Concomitant Prostate Cancer Treated with Radiation Therapy. Gastroenterology 2019, 156: s-867. DOI: 10.1016/s0016-5085(19)39129-2.
- Malter L, Jain A, Cohen B, Gaidos J, Axisa L, Butterfield L, Rescola B, Sarode S, Cheifetz A, Ehrlich O. 18 CLINICAL PRACTITIONERS’ EDUCATION AND RESOURCE NEEDS FOR INFLAMMATORY BOWEL DISEASES. Inflammatory Bowel Diseases 2019, 25: s1-s1. DOI: 10.1093/ibd/izy393.001.
- Feagins L, Kim J, Chandrakumaran A, Gandle C, Naik K, Hou J, Yao M, Gaidos J. P071 NO INCREASED RATE OF ADVERSE IBD-RELATED OUTCOMES FOR PATIENTS WITH IBD AND CONCURRENT PROSTATE CANCER TREATED WITH RADIATION THERAPY. Inflammatory Bowel Diseases 2019, 25: s34-s34. DOI: 10.1093/ibd/izy393.078.
- Feagins L, Kim J, Chandrakumaran A, Gandle C, Naik K, Hou J, Yao M, Gaidos J. P071 NO INCREASED RATE OF ADVERSE IBD-RELATED OUTCOMES FOR PATIENTS WITH IBD AND CONCURRENT PROSTATE CANCER TREATED WITH RADIATION THERAPY. Gastroenterology 2019, 156: s49-s50. DOI: 10.1053/j.gastro.2019.01.130.
- Malter L, Jain A, Cohen B, Gaidos J, Axisa L, Butterfield L, Rescola B, Sarode S, Cheifetz A, Ehrlich O. 18 CLINICAL PRACTITIONERS’ EDUCATION AND RESOURCE NEEDS FOR INFLAMMATORY BOWEL DISEASES. Gastroenterology 2019, 156: s1-s2. DOI: 10.1053/j.gastro.2019.01.045.
- Valluru N, Kang L, Gaidos JKJ. Health Maintenance Documentation Improves for Veterans with IBD Using a Template in the Computerized Patient Record System. Digestive Diseases And Sciences 2018, 63: 1782-1786. PMID: 29736836, DOI: 10.1007/s10620-018-5093-5.
- Gaidos J, Herbst K, Dave J, Yao M, Hou J, Smith A, Feagins L. Mo1812 - Prevalence and Risk Factors for Male Sexual Dysfunction in a Prospective Multicenter Va Inflammatory Bowel Disease Population. Gastroenterology 2018, 154: s-811. DOI: 10.1016/s0016-5085(18)32776-8.
- Govani S, Millien V, Ali S, Dave J, Hou J, Gaidos J, Yao M, Feagins L, Velligan D, Pugh J, Waljee A. P010 ADHERENCE TO INFLIXIMAB FOR INFLAMMATORY BOWEL DISEASE, A MULTICENTER RETROSPECTIVE REVIEW. Inflammatory Bowel Diseases 2018, 24: s5-s5. DOI: 10.1093/ibd/izy019.010.
- Herbst K, Kang L, Gaidos J. P058 INCREASES IN HEMOGLOBIN ARE ASSOCIATED WITH A DECREASED RISK FOR COLORECTAL CANCER IN VETERAN’S AFFAIRS INFLAMMATORY BOWEL DISEASE PATIENTS. Inflammatory Bowel Diseases 2018, 24: s22-s22. DOI: 10.1093/ibd/izy019.064.
- Herbst K, Kang L, Gaidos J. P058 INCREASES IN HEMOGLOBIN ARE ASSOCIATED WITH A DECREASED RISK FOR COLORECTAL CANCER IN VETERAN’S AFFAIRS INFLAMMATORY BOWEL DISEASE PATIENTS. Gastroenterology 2018, 154: s31. DOI: 10.1053/j.gastro.2017.11.096.
- Govani S, Millien V, Ali S, Dave J, Hou J, Gaidos J, Yao M, Feagins L, Velligan D, Pugh J, Waljee A. P010 ADHERENCE TO INFLIXIMAB FOR INFLAMMATORY BOWEL DISEASE, A MULTICENTER RETROSPECTIVE REVIEW. Gastroenterology 2018, 154: s6-s7. DOI: 10.1053/j.gastro.2017.11.042.
- Burke C, Lopez R, Oxentenko A, Gaidos J, Surawicz C. Gender Disparities in the Professional and Personal Lives of Gastroenterologists: A Nationwide Survey. The American Journal Of Gastroenterology 2017, 112: s613-s614. DOI: 10.14309/00000434-201710001-01122.
- Gaidos J, Kane S. Biologics in Pregnancy and Breastfeeding. 2017, 81-99. DOI: 10.1007/978-3-319-60276-9_6.
- Gaidos J, Kane S. Sexuality, Fertility, and Pregnancy in Crohn's Disease. Gastroenterology Clinics Of North America 2017, 46: 531-546. PMID: 28838413, DOI: 10.1016/j.gtc.2017.05.007.
- Feagins LA, Waljee A, Hou JK, Gu P, Kanjo S, Rudrapatna V, Cipher DJ, Govani S, Gaidos J. Incidence of and Predictors for Early Discontinuation of Biological Therapies in Veteran Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2017, 23: 1434-1439. PMID: 28570429, DOI: 10.1097/mib.0000000000001145.
- Valluru N, Gaidos J. Mo1811 Improving Health Maintenance in Veterans with Inflammatory Bowel Disease Using a Template in the Computerized Patient Record System. Gastroenterology 2017, 152: s787-s788. DOI: 10.1016/s0016-5085(17)32730-0.
- Gaidos JKJ, Fuchs M. Increased Prevalence of NAFLD in IBD Patients. Digestive Diseases And Sciences 2017, 62: 1362-1362. PMID: 28357696, DOI: 10.1007/s10620-017-4552-8.
- Gaidos JK, Kane SV. Managing IBD Therapies in Pregnancy. Current Treatment Options In Gastroenterology 2017, 15: 71-83. PMID: 28181180, DOI: 10.1007/s11938-017-0123-5.
- Alsaleh A, Gaidos JK, Kang L, Kuemmerle JF. Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients. Digestive Diseases And Sciences 2016, 61: 2602-2607. PMID: 27126205, PMCID: PMC4982818, DOI: 10.1007/s10620-016-4171-9.
- Feagins L, Waljee A, Hou J, Gu P, Kanjo S, Rudrapatna V, Ellis A, Govani S, Gaidos J. Sa1885 Incidence of and Predictors for Early Discontinuation of Biologic Therapies in Veteran Patients with Inflammatory Bowel Disease. Gastroenterology 2016, 150: s392. DOI: 10.1016/s0016-5085(16)31374-9.
- Thakur E, Waljee A, Gaidos J, Feagins L, Govani S, Sansgiry S, Kramer J, Dindo L, El-Serag H, Hou J. Su1842 The Incidence and Prevalence of Anxiety, Depression, and PTSD Among a National Cohort of U.S. Veterans With Inflammatory Bowel Disease. Gastroenterology 2016, 150: s567. DOI: 10.1016/s0016-5085(16)31941-2.
- Zhang H, Panara A, Waljee A, Gaidos J, Feagins L, Govani S, Thrift A, El-Serag H, Hou J. Su1833 Colorectal Cancer Is Diagnosed Earlier After Inflammatory Bowel Disease Diagnosis in African Americans Compared to Whites: A National Cohort Study. Gastroenterology 2016, 150: s565. DOI: 10.1016/s0016-5085(16)31932-1.
- Panara A, Zhang H, Waljee A, Gaidos J, Feagins L, Govani S, Thrift A, El-Serag H, Hou J. Su1816 Presence of Colonic Dysplasia prior to Colorectal Cancer Diagnosis is Associated with Early Stage Cancer among Patients with Inflammatory Bowel Disease: A National Cohort Study. Gastroenterology 2016, 150: s561. DOI: 10.1016/s0016-5085(16)31915-1.
- Gaidos J, Toor A, Roberts C, Chung H, Clark W, McCarty J, Sanyal A. Su1904 Role of the Gut Microbiome in Acute Graft Versus Host Disease: A Pilot Study. Gastroenterology 2016, 150: s584. DOI: 10.1016/s0016-5085(16)32003-0.
- Gaidos JK, Kane SV. Overcoming challenges of treating inflammatory bowel disease in pregnancy. Expert Review Of Clinical Immunology 2016, 12: 871-878. PMID: 26981845, DOI: 10.1586/1744666x.2016.1166958.
- Gaidos JK, Bickston SJ. How to Optimize Colon Cancer Surveillance in Inflammatory Bowel Disease Patients. Inflammatory Bowel Diseases 2016, 22: 1219-1230. PMID: 26926040, DOI: 10.1097/mib.0000000000000685.
- Gaidos J, Alsaleh A, Kuemmerle J. Timing of Last Preoperative Dose of Anti-Tumor Necrosis Factor α Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients. The American Journal Of Gastroenterology 2015, 110: s797. DOI: 10.14309/00000434-201510001-01877.
- Bien A, Banks K, Gaidos J, Kuemmerle J. A case of infectious mononucleosis in a patient with ulcerative colitis on infliximab. Case Reports In Internal Medicine 2014, 1 DOI: 10.5430/crim.v1n2p202.
- Bien A, Gaidos J, Kuemmerle J, Banks K. A Case of Infectious Mononucleosis in a Patient with Ulcerative Colitis on Infliximab. The American Journal Of Gastroenterology 2012, 107: s505. DOI: 10.14309/00000434-201210001-01271.
- Williamson JB, Judah JR, Gaidos JK, Collins DP, Wagh MS, Chauhan SS, Zoeb S, Buscaglia JM, Yan H, Hou W, Draganov PV. Prospective evaluation of the long-term outcomes after deep small-bowel spiral enteroscopy in patients with obscure GI bleeding. Gastrointestinal Endoscopy 2012, 76: 771-778. PMID: 22771101, DOI: 10.1016/j.gie.2012.05.025.
- Williamson J, Zoeb S, Buscaglia J, Gaidos J, Judah J, Collins D, Draganov P. Long-Term Outcomes after Deep Small Bowel Spiral Enteroscopy for Evaluation of Obscure Gastrointestinal (GI) Bleeding. The American Journal Of Gastroenterology 2011, 106: s547. DOI: 10.14309/00000434-201110002-01430.
- Nagula S, Gaidos J, Draganov PV, Bucobo JC, Cho B, Hernandez Y, Buscaglia JM. Retrograde spiral enteroscopy: feasibility, success, and safety in a series of 22 patients. Gastrointestinal Endoscopy 2011, 74: 699-702. PMID: 21762908, DOI: 10.1016/j.gie.2011.05.017.
- Alsaleh A, Gaidos J, Valentine J. Does BMI Influence the Development of Hepatotoxicity in Patients With Inflammatory Bowel Disease (IBD) and Elevated 6MMP Levels? Gastroenterology 2011, 140: s-772. DOI: 10.1016/s0016-5085(11)63202-2.
- Gaidos J, Judah J, Collins D, Draganov P. Prospective Evaluation of the Clinical Utility of Spiral Deep Small Bowel Enteroscopy (SBE) in Patients with Known or Suspected Crohnʼs Disease (CD). The American Journal Of Gastroenterology 2010, 105: s422. DOI: 10.14309/00000434-201010001-01163.
- Judah JR, Collins D, Gaidos JK, Hou W, Forsmark CE, Draganov PV. Prospective Evaluation of Gastroenterologist-Guided, Nurse-Administered Standard Sedation for Spiral Deep Small Bowel Enteroscopy. Digestive Diseases And Sciences 2010, 55: 2584-2591. PMID: 20632098, DOI: 10.1007/s10620-010-1335-x.
- Gaidos JK, Draganov PV. Treatment of malignant gastric outlet obstruction with endoscopically placed self-expandable metal stents. World Journal Of Gastroenterology 2009, 15: 4365-71. PMID: 19764086, PMCID: PMC2747055, DOI: 10.3748/wjg.15.4365.
- Gaidos JK, Hillner BE, Sanyal AJ. A decision analysis study of the value of a liver biopsy in nonalcoholic steatohepatitis. Liver International 2008, 28: 650-658. PMID: 18331241, DOI: 10.1111/j.1478-3231.2008.01693.x.
- Yale Digestive DiseasesTemple Medical Center40 Temple Street, Ste 1ANew Haven, CT 06510
- 8 Devine StreetNorth Haven, CT 06473
Biography
Jill Gaidos, MD, specializes in treating patients with inflammatory bowel disease (IBD), an umbrella term describing two conditions that cause chronic inflammation within the digestive system: ulcerative colitis and Crohn’s disease.
Dr. Gaidos says she was drawn to IBD because of its variety. “I like how sometimes I get to perform a procedure and see a patient only once; but, I also get to care for others over the span of many years,” she says. “You have to think about the entire patient—it’s a mix of acute and chronic cases.”
Dr. Gaidos enjoys helping patients better understand their IBD and the medications that can be used to help treat their colitis or Crohn’s disease. “My goal is to get the patient to return to enjoying life again,” she says. “It’s rewarding when a patient tells me they had no idea how bad they had been feeling until they started to feel better.”
As the director of clinical research for the Yale Inflammatory Bowel Disease Program, Dr. Gaidos helps patients understand the treatment options available, as not all IBD medications work for all IBD patients. “We are learning more about what causes ulcerative colitis and Crohn’s disease,” she says. “Hopefully, one day we will be able to better predict which patients we can put on a particular drug that will work for them.”
Titles
- Associate Professor of Medicine (Digestive Diseases)
- Director of Clinical Research, Yale Inflammatory Bowel Disease Program
- Vice Chief of Clinical Research, Digestive Diseases
Education & Training
- FellowUniversity of Florida (2011)
- ResidentVirginia Commonwealth University (2008)
- InternshipVirginia Commonwealth University (2006)
- MDVirginia Commonwealth University, Medicine (2005)
Additional Information
- Crohn’s and Colitis Foundation Women in IBD Leadership Program: (2022)
- American College of Gastroenterology Advanced Leadership Development Program: (2022)
- Cassell Connolly Top Doctor for 2022: (2022)
- 2021 Crohn’s and Colitis Congress, Crohn’s and Colitis Champion: (2020)
- 2020 Crohn’s and Colitis Congress, Crohn’s and Colitis Champion: (2019)
- Crohn’s and Colitis Foundation, Healthcare Provider Volunteer Award: (2018)
- American College of Gastroenterology, Fellow: (2014)
- American College of Gastroenterology, Chair: (2014)
- American College of Gastroenterology, Inflammatory Bowel Disease Abstract Award: (2012)
- Investing in the Future: Clinical Research in Inflammatory Bowel Disease Program: (2011)
- McMillan C, Li D, Mohamed G, Alsadoun D, Almohsen L, Gaidos J, Proctor D, Al-Bawardy B. Longer Colonoscopy Withdrawal Time Is Associated With the Detection of Visible Dysplasia in Patients With Inflammatory Bowel Disease. Crohn's & Colitis 360 2024, 6: otae020. PMID: 38585555, PMCID: PMC10998460, DOI: 10.1093/crocol/otae020.
- Sahyoun L, Fetene J, McMillan C, Protiva P, Al Bawardy B, Gaidos J, Proctor D. Impact of COVID-19 Treatment on Real-World Outcomes in Inflammatory Bowel Disease. Digestive Diseases And Sciences 2024, 69: 1654-1660. PMID: 38466459, DOI: 10.1007/s10620-024-08355-3.
- Sahyoun L, McMillan C, Fetene J, Protiva P, Al-Bawardy B, Gaidos J, Proctor D. S1000 Exploring the Influence of COVID-19 Treatment on Real-World Outcomes in IBD Patients: A Comprehensive Analysis. The American Journal Of Gastroenterology 2023, 118: s757-s757. DOI: 10.14309/01.ajg.0000953640.32433.d2.
- Almomen H, Alomar I, McMillan C, Gaidos J, Proctor D, AlMutairdi A, Al-Bawardy B. S1006 Comparison of Upadacitinib Induction in Tofacitinib Exposed and Naïve Patients With Inflammatory Bowel Disease: A Real World Multi-Center Study. The American Journal Of Gastroenterology 2023, 118: s761-s762. DOI: 10.14309/01.ajg.0000953664.83573.de.
- Levine L, Liang Y, McMillan C, Jain D, Mohamed G, Almohsen L, Alsadoun D, Gaidos J, Proctor D, Al-Bawardy B. S940 Histologic Healing in Crohn's Disease Is Not Associated With Long Term Outcomes. The American Journal Of Gastroenterology 2023, 118: s704-s705. DOI: 10.14309/01.ajg.0000953400.77190.37.
- Vasudevan J, Damianos J, DiVincenzo C, Gaidos J, Burgermaster M, Feagins L. S947 Why IBD Patients Aren’t Eating ‘an Apple a Day:’ Understanding Dietary Fiber Avoidance in Inflammatory Bowel Disease. The American Journal Of Gastroenterology 2023, 118: s710-s711. DOI: 10.14309/01.ajg.0000953428.77556.69.
- Chavez V, Vasudevan J, Ochi M, Sahyoun L, Kogan L, Anand T, Gaidos J, Feagins L. S1007 No Impact of Primary Language on Treatment and Outcomes for Patients With Inflammatory Bowel Disease in 2 Academic Medical Centers. The American Journal Of Gastroenterology 2023, 118: s762-s763. DOI: 10.14309/01.ajg.0000953668.62572.df.
- Xiao K, Gottesman S, Nguyen H, Hernandez E, Anand T, Saweris E, Jaganathan P, Jafri F, Davis J, Tong K, Gaidos J, Feagins L. S1009 Higher Rates of Delay in Starting Advanced Inflammatory Bowel Disease Therapy for Biologics Given Via Infusion Centers. The American Journal Of Gastroenterology 2023, 118: s764-s765. DOI: 10.14309/01.ajg.0000953676.10735.44.
- Hedrick T, Sherman A, Cohen-Mekelburg S, Gaidos J. AGA Clinical Practice Update on Management of Ostomies: Commentary. Clinical Gastroenterology And Hepatology 2023, 21: 2473-2477. PMID: 37498275, DOI: 10.1016/j.cgh.2023.04.035.
- Gaidos J, Bawardy B, Farraye F, Regueiro M. Use of Standardized Inflammatory Bowel Disease Endoscopy Scores in Clinical Practice. Crohn's & Colitis 360 2023, 5: otad037. PMID: 37559746, PMCID: PMC10407976, DOI: 10.1093/crocol/otad037.
- Sharma S, Li D, Levine L, Chaar A, McMillan C, Gaidos J, Proctor D, Al-Bawardy B. Early Flexible Sigmoidoscopy Improves Clinical Outcomes in Acute Severe Ulcerative Colitis. Crohn's & Colitis 360 2023, 5: otad032. PMID: 37323477, PMCID: PMC10263117, DOI: 10.1093/crocol/otad032.
- Vasudevan J, Larson D, Damianos J, Shori C, DiVincenzo C, Ishola Y, Gaidos J, Burgermaster M, Feagins L. Mo1714 DIETARY FIBER INTAKE ASSOCIATED WITH REDUCED IBD DISEASE ACTIVITY. Gastroenterology 2023, 164: s-876-s-877. DOI: 10.1016/s0016-5085(23)03024-x.
- Almomen H, Sayed A, Chipkin B, Nawaz A, Gaidos J, Proctor D, Bawardy B. Tu1796 OUTCOMES OF ACCELERATED VS. STANDARD INFLIXIMAB INDUCTION DOSE IN CROHN'S DISEASE. Gastroenterology 2023, 164: s-1132. DOI: 10.1016/s0016-5085(23)03611-9.
- McMillan C, Li D, Gaidos J, Proctor D, Bawardy B. 113 LONGER COLONOSCOPY WITHDRAWAL TIME IS ASSOCIATED WITH THE DETECTION OF POLYPOID DYSPLASIA IN INFLAMMATORY BOWEL DISEASE. Gastroenterology 2023, 164: s-16. DOI: 10.1016/s0016-5085(23)00993-9.
- Al-Bawardy B, Malter L, Ehrlich A, Rieder F, Gaidos J, Proctor D, Windish D. Assessment of Inflammatory Bowel Disease Training Among Gastroenterology Fellows. Inflammatory Bowel Diseases 2023, 29: 1990-1992. PMID: 36810663, DOI: 10.1093/ibd/izad030.
- Sayed A, Assis D, Silveira M, Deng Y, Ciarleglio M, Gaidos J, Proctor D, Al-Bawardy B. Outcomes of immunomodulator and advanced therapies for primary sclerosing cholangitis-associated inflammatory bowel disease. European Journal Of Gastroenterology & Hepatology 2023, 35: 270-274. PMID: 36708297, DOI: 10.1097/meg.0000000000002510.
- Sahyoun L, Gaidos J. A Practical Approach to IBD Care in the Pregnant Patient. Current Gastroenterology Reports 2022, 24: 201-209. PMID: 36422770, DOI: 10.1007/s11894-022-00856-3.
- Anderson J, Bilal M, Burke C, Gaidos J, Lopez R, Oxentenko A, Surawicz C. Burnout Among US Gastroenterologists and Fellows in Training. Journal Of Clinical Gastroenterology 2022, 57: 1063-1069. PMID: 36477385, DOI: 10.1097/mcg.0000000000001781.
- Sharma S, Li D, Levine L, Chaar A, McMillan C, Gaidos J, Proctor D, Al-Bawardy B. S856 Predictors of Colectomy in Acute Severe Ulcerative Colitis. The American Journal Of Gastroenterology 2022, 117: e618-e619. DOI: 10.14309/01.ajg.0000860064.59694.03.
- Nawaz A, Chaar A, Li D, Gaidos J, Proctor D, Al-Bawardy B. S863 Impact of Race on ANTI-TNF Immunogenicity in Patients with Inflammatory Bowel Disease. The American Journal Of Gastroenterology 2022, 117: e623-e624. DOI: 10.14309/01.ajg.0000860092.19979.d5.
- McMillan C, Levine L, Gaidos J, Proctor D, Al-Bawardy B, Jain D, Liang Y. S862 Rates and Outcomes of Histologic Healing in Crohn's Disease. The American Journal Of Gastroenterology 2022, 117: e622-e623. DOI: 10.14309/01.ajg.0000860088.69814.32.
- Al-Bawardy B, Malter L, Ehrlich A, Rieder F, Gaidos J, Proctor D, Windish D. S875 Assessment of Inflammatory Bowel Disease Training Among Gastroenterology Fellows. The American Journal Of Gastroenterology 2022, 117: e632-e632. DOI: 10.14309/01.ajg.0000860140.96667.49.
- Shori C, Damianos J, DiVincenzo C, Ishola Y, Larson D, Burgermaster M, Gaidos J, Feagins L. S1011 Inflammatory Bowel Disease Patients Commonly but Inconsistently Change Diet for Flares. The American Journal Of Gastroenterology 2022, 117: e732-e733. DOI: 10.14309/01.ajg.0000860684.14143.a0.
- Feagins L, Moore P, Crabtree M, Lemay C, Loughlin A, Gaidos J. S883 Impact of Fatigue on Work Productivity and Activity Impairment and Health Care Utilization in Patients With Inflammatory Bowel Disease. The American Journal Of Gastroenterology 2022, 117: e639-e640. DOI: 10.14309/01.ajg.0000860172.94404.2d.
- Gaidos J, Al-Bawardy B, Farraye F, Regueiro M. S1013 Use of IBD Endoscopic Scoring Systems in Practice. The American Journal Of Gastroenterology 2022, 117: e733-e734. DOI: 10.14309/01.ajg.0000860692.83055.c3.
- Di Vincenzo C, Damianos J, Shori C, Ishola Y, Chebaa B, Koshar P, Burgermaster M, Gaidos J, Feagins L. Tu1434: RETHINKING LOW FIBER DIETS FOR ACTIVE INFLAMMATORY BOWEL DISEASE. Gastroenterology 2022, 162: s-958. DOI: 10.1016/s0016-5085(22)62272-8.
- Sharma S, Levine L, McMillan C, Li D, Gaidos J, Proctor D, Bawardy B. Mo1547: IMPACT OF EARLY VS DELAYED FLEXIBLE SIGMOIDOSCOPY ON OUTCOMES IN INPATIENT SEVERE ULCERATIVE COLITIS. Gastroenterology 2022, 162: s-813. DOI: 10.1016/s0016-5085(22)61919-x.
- Levine L, Sharma S, McMillan C, Li D, Gaidos J, Proctor D, Bawardy B. Tu1429: FREQUENCY AND CHARACTERISTICS OF NUTRITION ASSESSMENT IN HOSPITALIZED ULCERATIVE COLITIS PATIENTS. Gastroenterology 2022, 162: s-957. DOI: 10.1016/s0016-5085(22)62267-4.
- Sayed A, Silveira M, Assis D, Deng Y, Gaidos J, Proctor D, Al-Bawardy B. PREDICTORS AND OUTCOMES OF BIOLOGIC/IMMUNOSUPPRESSIVE THERAPY FOR PSC-ASSOCIATED IBD. Gastroenterology 2022, 162: s76. DOI: 10.1053/j.gastro.2021.12.161.
- Petrov J, Al-Bawardy B, Gaidos J, Proctor D. OUTCOMES OF TOTAL PROCTOCOLECTOMY (TPC) WITH ILEAL POUCH ANAL ANASTOMOSIS (IPAA). Gastroenterology 2022, 162: s75-s76. DOI: 10.1053/j.gastro.2021.12.160.
- Nawaz A, Glick L, Li D, Gaidos J, Proctor D, Al-Bawardy B. IMPACT OF THIOPURINE DOSE IN COMBINATION THERAPY IN INFLAMMATORY BOWEL DISEASE. Gastroenterology 2022, 162: s107-s108. DOI: 10.1053/j.gastro.2021.12.221.
- Sayed A, Silveira M, Assis D, Deng Y, Gaidos J, Proctor D, Al-Bawardy B. PREDICTORS AND OUTCOMES OF BIOLOGIC/IMMUNOSUPPRESSIVE THERAPY FOR PSC-ASSOCIATED IBD. Inflammatory Bowel Diseases 2022, 28: s76-s76. DOI: 10.1093/ibd/izac015.124.
- Petrov J, Al-Bawardy B, Gaidos J, Proctor D. OUTCOMES OF TOTAL PROCTOCOLECTOMY (TPC) WITH ILEAL POUCH ANAL ANASTOMOSIS (IPAA). Inflammatory Bowel Diseases 2022, 28: s75-s76. DOI: 10.1093/ibd/izac015.123.
- Nawaz A, Glick L, Li D, Gaidos J, Proctor D, Al-Bawardy B. IMPACT OF THIOPURINE DOSE IN COMBINATION THERAPY IN INFLAMMATORY BOWEL DISEASE. Inflammatory Bowel Diseases 2022, 28: s107-s108. DOI: 10.1093/ibd/izac015.174.
- Nawaz A, Glick L, Chaar A, Li D, Gaidos J, Proctor D, Al-Bawardy B. Impact of thiopurine dose in anti-tumor necrosis factor combination therapy on outcomes in inflammatory bowel disease. Annals Of Gastroenterology 2022, 36: 39-44. PMID: 36593807, PMCID: PMC9756033, DOI: 10.20524/aog.2022.0766.
- Levine L, Gaidos J, Proctor D, Viana A, Bawardy B. Su465 EFFECT OF OBESITY ON VEDOLIZUMAB RESPONSE IN INFLAMMATORY BOWEL DISEASE. Gastroenterology 2021, 160: s-703-s-704. DOI: 10.1016/s0016-5085(21)02387-8.
- Li M, Khan S, Gaidos J, Proctor D, Bawardy B. Sa566 OUTCOMES OF INFLAMMATORY BOWEL DISEASE WITH CONCOMITANT ADVANCED LIVER FIBROSIS AND CIRRHOSIS. Gastroenterology 2021, 160: s-554. DOI: 10.1016/s0016-5085(21)02022-9.
- Levine L, Gaidos J, Proctor D, Bawardy B. Su464 PREDICTORS AND OUTCOMES OF VEDOLIZUMAB DOSE ESCALATION IN INFLAMMATORY BOWEL DISEASE. Gastroenterology 2021, 160: s-703. DOI: 10.1016/s0016-5085(21)02386-6.
- Li M, Khan S, Proctor D, Gaidos J, Al-Bawardy B. THE SAFETY, TOLERABILITY, AND EFFECTIVENESS OF BIOLOGICS/SMALL MOLECULE THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND CIRRHOSIS. Gastroenterology 2021, 160: s62. DOI: 10.1053/j.gastro.2021.01.159.
- Li M, Khan S, Proctor D, Gaidos J, Al-Bawardy B. THE SAFETY, TOLERABILITY, AND EFFECTIVENESS OF BIOLOGICS/SMALL MOLECULE THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND CIRRHOSIS. Inflammatory Bowel Diseases 2021, 27: s45-s46. DOI: 10.1093/ibd/izaa347.110.
- Gaidos JKJ, Kane SV. Medication Adherence During Pregnancy in IBD: Compliance Avoids Complications. Digestive Diseases And Sciences 2020, 66: 336-337. PMID: 32323073, DOI: 10.1007/s10620-020-06271-w.
- Malter L, Jain A, Cohen BL, Gaidos JKJ, Axisa L, Butterfield L, Rescola BJ, Sarode S, Ehrlich O, Cheifetz AS. Identifying IBD Providers’ Knowledge Gaps Using a Prospective Web-based Survey. Inflammatory Bowel Diseases 2020, 26: 1445-1450. PMID: 32100018, DOI: 10.1093/ibd/izaa032.
- Gaidos J, Naik K, Dave J, Yao M, Hou J, Cipher D, Smith A, Feagins L. High Prevalence of Male Sexual Dysfunction in a Prospective Multicenter VA Inflammatory Bowel Disease Population. Crohn's & Colitis 360 2020, 2: otaa004. PMID: 36777954, PMCID: PMC9801960, DOI: 10.1093/crocol/otaa004.
- Thakur ER, Sansgiry S, Kramer JR, Waljee AK, Gaidos JK, Feagins LA, Govani SM, Dindo L, El-Serag HB, Hou JK. The Incidence and Prevalence of Anxiety, Depression, and Post-traumatic Stress Disorder in a National Cohort of US Veterans With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2019, 26: 1423-1428. PMID: 31728520, PMCID: PMC7441098, DOI: 10.1093/ibd/izz280.
- Pawa S, Banerjee P, Kothari S, D'Souza S, Martindale S, Gaidos J, Oxentenko A, Burke C. 515 Are All Endoscopic-Related Musculoskeletal Injuries Created Equal?: Results of a National Gender-Based Survey. The American Journal Of Gastroenterology 2019, 114: s299-s299. DOI: 10.14309/01.ajg.0000591592.66925.e8.
- Feagins LA, Kim J, Chandrakumaran A, Gandle C, Naik KH, Cipher DJ, Hou JK, Yao MD, Gaidos JKJ. Rates of Adverse IBD-Related Outcomes for Patients With IBD and Concomitant Prostate Cancer Treated With Radiation Therapy. Inflammatory Bowel Diseases 2019, 26: 728-733. PMID: 31412114, DOI: 10.1093/ibd/izz175.
- Love B, Finney C, Gaidos J. Sa1782 – Effect of Vaccination and Immunosuppressive Medications on Invasive Pneumococcal Disease Occurrence in Veterans with Inflammatory Bowel Disease. Gastroenterology 2019, 156: s-400. DOI: 10.1016/s0016-5085(19)37849-7.
- Feagins L, Kim J, Chandrakumaran A, Gandle C, Naik K, Hou J, Yao M, Gaidos J. Mo1862 – No Increaed Rates of Adverse Ibd-Related Outcomes for Patients with IBD and Concomitant Prostate Cancer Treated with Radiation Therapy. Gastroenterology 2019, 156: s-867. DOI: 10.1016/s0016-5085(19)39129-2.
- Malter L, Jain A, Cohen B, Gaidos J, Axisa L, Butterfield L, Rescola B, Sarode S, Cheifetz A, Ehrlich O. 18 CLINICAL PRACTITIONERS’ EDUCATION AND RESOURCE NEEDS FOR INFLAMMATORY BOWEL DISEASES. Inflammatory Bowel Diseases 2019, 25: s1-s1. DOI: 10.1093/ibd/izy393.001.
- Feagins L, Kim J, Chandrakumaran A, Gandle C, Naik K, Hou J, Yao M, Gaidos J. P071 NO INCREASED RATE OF ADVERSE IBD-RELATED OUTCOMES FOR PATIENTS WITH IBD AND CONCURRENT PROSTATE CANCER TREATED WITH RADIATION THERAPY. Inflammatory Bowel Diseases 2019, 25: s34-s34. DOI: 10.1093/ibd/izy393.078.
- Feagins L, Kim J, Chandrakumaran A, Gandle C, Naik K, Hou J, Yao M, Gaidos J. P071 NO INCREASED RATE OF ADVERSE IBD-RELATED OUTCOMES FOR PATIENTS WITH IBD AND CONCURRENT PROSTATE CANCER TREATED WITH RADIATION THERAPY. Gastroenterology 2019, 156: s49-s50. DOI: 10.1053/j.gastro.2019.01.130.
- Malter L, Jain A, Cohen B, Gaidos J, Axisa L, Butterfield L, Rescola B, Sarode S, Cheifetz A, Ehrlich O. 18 CLINICAL PRACTITIONERS’ EDUCATION AND RESOURCE NEEDS FOR INFLAMMATORY BOWEL DISEASES. Gastroenterology 2019, 156: s1-s2. DOI: 10.1053/j.gastro.2019.01.045.
- Valluru N, Kang L, Gaidos JKJ. Health Maintenance Documentation Improves for Veterans with IBD Using a Template in the Computerized Patient Record System. Digestive Diseases And Sciences 2018, 63: 1782-1786. PMID: 29736836, DOI: 10.1007/s10620-018-5093-5.
- Gaidos J, Herbst K, Dave J, Yao M, Hou J, Smith A, Feagins L. Mo1812 - Prevalence and Risk Factors for Male Sexual Dysfunction in a Prospective Multicenter Va Inflammatory Bowel Disease Population. Gastroenterology 2018, 154: s-811. DOI: 10.1016/s0016-5085(18)32776-8.
- Govani S, Millien V, Ali S, Dave J, Hou J, Gaidos J, Yao M, Feagins L, Velligan D, Pugh J, Waljee A. P010 ADHERENCE TO INFLIXIMAB FOR INFLAMMATORY BOWEL DISEASE, A MULTICENTER RETROSPECTIVE REVIEW. Inflammatory Bowel Diseases 2018, 24: s5-s5. DOI: 10.1093/ibd/izy019.010.
- Herbst K, Kang L, Gaidos J. P058 INCREASES IN HEMOGLOBIN ARE ASSOCIATED WITH A DECREASED RISK FOR COLORECTAL CANCER IN VETERAN’S AFFAIRS INFLAMMATORY BOWEL DISEASE PATIENTS. Inflammatory Bowel Diseases 2018, 24: s22-s22. DOI: 10.1093/ibd/izy019.064.
- Herbst K, Kang L, Gaidos J. P058 INCREASES IN HEMOGLOBIN ARE ASSOCIATED WITH A DECREASED RISK FOR COLORECTAL CANCER IN VETERAN’S AFFAIRS INFLAMMATORY BOWEL DISEASE PATIENTS. Gastroenterology 2018, 154: s31. DOI: 10.1053/j.gastro.2017.11.096.
- Govani S, Millien V, Ali S, Dave J, Hou J, Gaidos J, Yao M, Feagins L, Velligan D, Pugh J, Waljee A. P010 ADHERENCE TO INFLIXIMAB FOR INFLAMMATORY BOWEL DISEASE, A MULTICENTER RETROSPECTIVE REVIEW. Gastroenterology 2018, 154: s6-s7. DOI: 10.1053/j.gastro.2017.11.042.
- Burke C, Lopez R, Oxentenko A, Gaidos J, Surawicz C. Gender Disparities in the Professional and Personal Lives of Gastroenterologists: A Nationwide Survey. The American Journal Of Gastroenterology 2017, 112: s613-s614. DOI: 10.14309/00000434-201710001-01122.
- Gaidos J, Kane S. Biologics in Pregnancy and Breastfeeding. 2017, 81-99. DOI: 10.1007/978-3-319-60276-9_6.
- Gaidos J, Kane S. Sexuality, Fertility, and Pregnancy in Crohn's Disease. Gastroenterology Clinics Of North America 2017, 46: 531-546. PMID: 28838413, DOI: 10.1016/j.gtc.2017.05.007.
- Feagins LA, Waljee A, Hou JK, Gu P, Kanjo S, Rudrapatna V, Cipher DJ, Govani S, Gaidos J. Incidence of and Predictors for Early Discontinuation of Biological Therapies in Veteran Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2017, 23: 1434-1439. PMID: 28570429, DOI: 10.1097/mib.0000000000001145.
- Valluru N, Gaidos J. Mo1811 Improving Health Maintenance in Veterans with Inflammatory Bowel Disease Using a Template in the Computerized Patient Record System. Gastroenterology 2017, 152: s787-s788. DOI: 10.1016/s0016-5085(17)32730-0.
- Gaidos JKJ, Fuchs M. Increased Prevalence of NAFLD in IBD Patients. Digestive Diseases And Sciences 2017, 62: 1362-1362. PMID: 28357696, DOI: 10.1007/s10620-017-4552-8.
- Gaidos JK, Kane SV. Managing IBD Therapies in Pregnancy. Current Treatment Options In Gastroenterology 2017, 15: 71-83. PMID: 28181180, DOI: 10.1007/s11938-017-0123-5.
- Alsaleh A, Gaidos JK, Kang L, Kuemmerle JF. Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients. Digestive Diseases And Sciences 2016, 61: 2602-2607. PMID: 27126205, PMCID: PMC4982818, DOI: 10.1007/s10620-016-4171-9.
- Feagins L, Waljee A, Hou J, Gu P, Kanjo S, Rudrapatna V, Ellis A, Govani S, Gaidos J. Sa1885 Incidence of and Predictors for Early Discontinuation of Biologic Therapies in Veteran Patients with Inflammatory Bowel Disease. Gastroenterology 2016, 150: s392. DOI: 10.1016/s0016-5085(16)31374-9.
- Thakur E, Waljee A, Gaidos J, Feagins L, Govani S, Sansgiry S, Kramer J, Dindo L, El-Serag H, Hou J. Su1842 The Incidence and Prevalence of Anxiety, Depression, and PTSD Among a National Cohort of U.S. Veterans With Inflammatory Bowel Disease. Gastroenterology 2016, 150: s567. DOI: 10.1016/s0016-5085(16)31941-2.
- Zhang H, Panara A, Waljee A, Gaidos J, Feagins L, Govani S, Thrift A, El-Serag H, Hou J. Su1833 Colorectal Cancer Is Diagnosed Earlier After Inflammatory Bowel Disease Diagnosis in African Americans Compared to Whites: A National Cohort Study. Gastroenterology 2016, 150: s565. DOI: 10.1016/s0016-5085(16)31932-1.
- Panara A, Zhang H, Waljee A, Gaidos J, Feagins L, Govani S, Thrift A, El-Serag H, Hou J. Su1816 Presence of Colonic Dysplasia prior to Colorectal Cancer Diagnosis is Associated with Early Stage Cancer among Patients with Inflammatory Bowel Disease: A National Cohort Study. Gastroenterology 2016, 150: s561. DOI: 10.1016/s0016-5085(16)31915-1.
- Gaidos J, Toor A, Roberts C, Chung H, Clark W, McCarty J, Sanyal A. Su1904 Role of the Gut Microbiome in Acute Graft Versus Host Disease: A Pilot Study. Gastroenterology 2016, 150: s584. DOI: 10.1016/s0016-5085(16)32003-0.
- Gaidos JK, Kane SV. Overcoming challenges of treating inflammatory bowel disease in pregnancy. Expert Review Of Clinical Immunology 2016, 12: 871-878. PMID: 26981845, DOI: 10.1586/1744666x.2016.1166958.
- Gaidos JK, Bickston SJ. How to Optimize Colon Cancer Surveillance in Inflammatory Bowel Disease Patients. Inflammatory Bowel Diseases 2016, 22: 1219-1230. PMID: 26926040, DOI: 10.1097/mib.0000000000000685.
- Gaidos J, Alsaleh A, Kuemmerle J. Timing of Last Preoperative Dose of Anti-Tumor Necrosis Factor α Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients. The American Journal Of Gastroenterology 2015, 110: s797. DOI: 10.14309/00000434-201510001-01877.
- Bien A, Banks K, Gaidos J, Kuemmerle J. A case of infectious mononucleosis in a patient with ulcerative colitis on infliximab. Case Reports In Internal Medicine 2014, 1 DOI: 10.5430/crim.v1n2p202.
- Bien A, Gaidos J, Kuemmerle J, Banks K. A Case of Infectious Mononucleosis in a Patient with Ulcerative Colitis on Infliximab. The American Journal Of Gastroenterology 2012, 107: s505. DOI: 10.14309/00000434-201210001-01271.
- Williamson JB, Judah JR, Gaidos JK, Collins DP, Wagh MS, Chauhan SS, Zoeb S, Buscaglia JM, Yan H, Hou W, Draganov PV. Prospective evaluation of the long-term outcomes after deep small-bowel spiral enteroscopy in patients with obscure GI bleeding. Gastrointestinal Endoscopy 2012, 76: 771-778. PMID: 22771101, DOI: 10.1016/j.gie.2012.05.025.
- Williamson J, Zoeb S, Buscaglia J, Gaidos J, Judah J, Collins D, Draganov P. Long-Term Outcomes after Deep Small Bowel Spiral Enteroscopy for Evaluation of Obscure Gastrointestinal (GI) Bleeding. The American Journal Of Gastroenterology 2011, 106: s547. DOI: 10.14309/00000434-201110002-01430.
- Nagula S, Gaidos J, Draganov PV, Bucobo JC, Cho B, Hernandez Y, Buscaglia JM. Retrograde spiral enteroscopy: feasibility, success, and safety in a series of 22 patients. Gastrointestinal Endoscopy 2011, 74: 699-702. PMID: 21762908, DOI: 10.1016/j.gie.2011.05.017.
- Alsaleh A, Gaidos J, Valentine J. Does BMI Influence the Development of Hepatotoxicity in Patients With Inflammatory Bowel Disease (IBD) and Elevated 6MMP Levels? Gastroenterology 2011, 140: s-772. DOI: 10.1016/s0016-5085(11)63202-2.
- Gaidos J, Judah J, Collins D, Draganov P. Prospective Evaluation of the Clinical Utility of Spiral Deep Small Bowel Enteroscopy (SBE) in Patients with Known or Suspected Crohnʼs Disease (CD). The American Journal Of Gastroenterology 2010, 105: s422. DOI: 10.14309/00000434-201010001-01163.
- Judah JR, Collins D, Gaidos JK, Hou W, Forsmark CE, Draganov PV. Prospective Evaluation of Gastroenterologist-Guided, Nurse-Administered Standard Sedation for Spiral Deep Small Bowel Enteroscopy. Digestive Diseases And Sciences 2010, 55: 2584-2591. PMID: 20632098, DOI: 10.1007/s10620-010-1335-x.
- Gaidos JK, Draganov PV. Treatment of malignant gastric outlet obstruction with endoscopically placed self-expandable metal stents. World Journal Of Gastroenterology 2009, 15: 4365-71. PMID: 19764086, PMCID: PMC2747055, DOI: 10.3748/wjg.15.4365.
- Gaidos JK, Hillner BE, Sanyal AJ. A decision analysis study of the value of a liver biopsy in nonalcoholic steatohepatitis. Liver International 2008, 28: 650-658. PMID: 18331241, DOI: 10.1111/j.1478-3231.2008.01693.x.
- Yale Digestive DiseasesTemple Medical Center40 Temple Street, Ste 1ANew Haven, CT 06510
- 8 Devine StreetNorth Haven, CT 06473
- Yale Digestive DiseasesTemple Medical Center40 Temple Street, Ste 1ANew Haven, CT 06510
- 8 Devine StreetNorth Haven, CT 06473